Legis Daily

Affordable Insulin for the COVID–19 Emergency Act

USA116th CongressHR-7062| House 
| Updated: 5/28/2020
Maxine Waters

Maxine Waters

Democratic Representative

California

Cosponsors (43)
Sylvia R. Garcia (Democratic)Barbara Lee (Democratic)Raúl M. Grijalva (Democratic)Mark Pocan (Democratic)Karen Bass (Democratic)Joyce Beatty (Democratic)Darren Soto (Democratic)Sheila Jackson Lee (Democratic)Sanford D. Bishop (Democratic)David Scott (Democratic)Frederica S. Wilson (Democratic)Bobby L. Rush (Democratic)Steve Cohen (Democratic)Donald M. Payne (Democratic)Thomas R. Suozzi (Democratic)Anthony G. Brown (Democratic)Lucille Roybal-Allard (Democratic)Peter A. DeFazio (Democratic)Daniel T. Kildee (Democratic)André Carson (Democratic)John B. Larson (Democratic)Joseph D. Morelle (Democratic)Gregory W. Meeks (Democratic)Jahana Hayes (Democratic)Marcia L. Fudge (Democratic)Eleanor Holmes Norton (Democratic)Mary Gay Scanlon (Democratic)Daniel Lipinski (Democratic)Joe Neguse (Democratic)Nydia M. Velázquez (Democratic)Eddie Bernice Johnson (Democratic)Jose E. Serrano (Democratic)Peter Welch (Democratic)Bennie G. Thompson (Democratic)Nanette Diaz Barragán (Democratic)Jesús G. "Chuy" García (Democratic)Grace Meng (Democratic)Rashida Tlaib (Democratic)Alcee L. Hastings (Democratic)Lauren Underwood (Democratic)Grace F. Napolitano (Democratic)Susan Wild (Democratic)Judy Chu (Democratic)

Ways and Means Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Affordable Insulin for the COVID-19 Emergency Act This bill eliminates cost-sharing under the Medicare prescription drug benefit and Medicare Advantage for insulin and associated medical supplies during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). The bill also allows beneficiaries to receive their insulin and supplies via mail order during the emergency period.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 28, 2020
Introduced in House
May 28, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • May 28, 2020
    Introduced in House
  • May 28, 2020
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Health

Cardiovascular and respiratory healthDigestive and metabolic diseasesDrug therapyEmergency medical services and trauma careHealth care coverage and accessHealth technology, devices, suppliesInfectious and parasitic diseasesMedicarePrescription drugs

Affordable Insulin for the COVID–19 Emergency Act

USA116th CongressHR-7062| House 
| Updated: 5/28/2020
Affordable Insulin for the COVID-19 Emergency Act This bill eliminates cost-sharing under the Medicare prescription drug benefit and Medicare Advantage for insulin and associated medical supplies during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). The bill also allows beneficiaries to receive their insulin and supplies via mail order during the emergency period.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 28, 2020
Introduced in House
May 28, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • May 28, 2020
    Introduced in House
  • May 28, 2020
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Maxine Waters

Maxine Waters

Democratic Representative

California

Cosponsors (43)
Sylvia R. Garcia (Democratic)Barbara Lee (Democratic)Raúl M. Grijalva (Democratic)Mark Pocan (Democratic)Karen Bass (Democratic)Joyce Beatty (Democratic)Darren Soto (Democratic)Sheila Jackson Lee (Democratic)Sanford D. Bishop (Democratic)David Scott (Democratic)Frederica S. Wilson (Democratic)Bobby L. Rush (Democratic)Steve Cohen (Democratic)Donald M. Payne (Democratic)Thomas R. Suozzi (Democratic)Anthony G. Brown (Democratic)Lucille Roybal-Allard (Democratic)Peter A. DeFazio (Democratic)Daniel T. Kildee (Democratic)André Carson (Democratic)John B. Larson (Democratic)Joseph D. Morelle (Democratic)Gregory W. Meeks (Democratic)Jahana Hayes (Democratic)Marcia L. Fudge (Democratic)Eleanor Holmes Norton (Democratic)Mary Gay Scanlon (Democratic)Daniel Lipinski (Democratic)Joe Neguse (Democratic)Nydia M. Velázquez (Democratic)Eddie Bernice Johnson (Democratic)Jose E. Serrano (Democratic)Peter Welch (Democratic)Bennie G. Thompson (Democratic)Nanette Diaz Barragán (Democratic)Jesús G. "Chuy" García (Democratic)Grace Meng (Democratic)Rashida Tlaib (Democratic)Alcee L. Hastings (Democratic)Lauren Underwood (Democratic)Grace F. Napolitano (Democratic)Susan Wild (Democratic)Judy Chu (Democratic)

Ways and Means Committee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Cardiovascular and respiratory healthDigestive and metabolic diseasesDrug therapyEmergency medical services and trauma careHealth care coverage and accessHealth technology, devices, suppliesInfectious and parasitic diseasesMedicarePrescription drugs